STOCK TITAN

Pascal Deschatelets (NASDAQ: APLS) files Rule 144 sale notice

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Pascal Deschatelets has filed a Form 144 notice relating to common stock of APLS, indicating an intent to sell 909 shares through Fidelity Brokerage Services on NASDAQ, with an approximate sale date of 01/20/2026. These 909 shares were acquired on 01/16/2026 via restricted stock vesting from the issuer as compensation.

The notice also reports that during the past three months, Deschatelets sold 2,277 common shares for gross proceeds of 50520.25. The filing lists 126,525,218 shares of this class outstanding, providing context for the size of the planned and recent sales.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the APLS Form 144 filed by Pascal Deschatelets disclose?

It discloses that Pascal Deschatelets plans to sell 909 shares of APLS common stock on NASDAQ through Fidelity Brokerage Services LLC, with an approximate sale date of 01/20/2026.

How many APLS shares is Pascal Deschatelets planning to sell under this Form 144?

The Form 144 states that 909 common shares are planned to be sold, with an aggregate market value of 17991.75 at the time of the notice.

How and when did Pascal Deschatelets acquire the APLS shares to be sold?

The filing shows that the 909 shares were acquired on 01/16/2026 through restricted stock vesting from the issuer, with the nature of payment listed as compensation.

What APLS share sales has Pascal Deschatelets reported in the past three months?

Over the past three months, Deschatelets reported selling 2,277 common shares on 01/13/2026, generating gross proceeds of 50520.25.

How many APLS common shares are reported as outstanding in this Form 144?

The securities information table lists 126,525,218 common shares as the number of shares outstanding for this class of APLS stock.

What type of transaction is this APLS Form 144 related to under Rule 144?

The Form 144 is a notice of proposed sale under Rule 144, covering the planned sale of restricted common shares acquired via restricted stock vesting and reported together with other recent sales by the same person.
Apellis Pharmace

NASDAQ:APLS

APLS Rankings

APLS Latest News

APLS Latest SEC Filings

APLS Stock Data

2.59B
106.56M
13.68%
105.74%
16.26%
Biotechnology
Pharmaceutical Preparations
Link
United States
WALTHAM